BIRMINGHAM, AL / ACCESSWIRE / January 11, 2024 / BioGX, a leading global provider of easy molecular diagnostic solutions, is pleased to announce the test menu expansion support to Departments of Health (DoH) with the addition of its Candida auris assay. BioGX currently services 6 DoH agencies with expansion to 10 agencies expected in Q1 2024.
“We are excited to support the state Departments of Health by providing menu expansion solutions to meet stringent assay performance requirements,” said Shahin Iqbal, PhD, BioGX President & COO. “Our goal is to empower healthcare professionals with the best tools available, and this expansion is a testament to our commitment to improving public health outcomes in the region.”
As healthcare continues to evolve, the importance of robust and accurate diagnostic solutions has never been more critical. BioGX is committed to providing innovative and reliable molecular diagnostics solutions to support public health initiatives. State health departments play a pivotal role in safeguarding public health, requiring cutting-edge molecular diagnostics to quickly respond to the ever-changing landscape of testing needs.
This expansion will provide Departments of Health with access to BioGX’s molecular assays, which are designed for speed, precision, and reliability. These assays may assist in the rapid and accurate detection of pathogens, contributing to more effective disease control and management.
BioGX has a proven track record of providing reliable solutions that are easy to use and adhere to high stringency standards of performance. By expanding the test menu, the company is ensuring that healthcare providers have access to a broad range of tools to best serve their communities.
About BioGX:
BioGX is a global leader in providing molecular diagnostic solutions designed to enhance the accuracy and efficiency of diagnostic testing. The company’s innovative technologies enable faster and more reliable results for a wide range of applications. BioGX Sample-Ready™ PCR assay* is for use on many real-time PCR instruments including the BD MAX™, ThermoFisher QuantStudio™, Bio-Rad CFX Touch™ and the new BioGX pixl™ platform.
BioGX’s Sample-Ready™ line of products for use on many real-time PCR instruments including the BD MAX™, ThermoFisher QuantStudio™, Bio-Rad CFX Touch™ BioGX pixl™ are offered as custom manufactured or Research Use Only PCR assays, lyophilized in a single vial and fine-tuned to ensure high performance across multiple platforms that are commonly used in laboratories today.
For more information, please visit www.biogx.com
*Research Use Only or Custom Manufacture Only.
Sample-Ready, Just Add Water, Xfree and pixl are trademarks of BioGX, Inc.
Contact Information
BIll Standwill
Global Head of Commercial
bill.standwill@biogx.com
205-250-8055
SOURCE: BioGX
View the original press release on newswire.com.
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…